BDBM493530 5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thioxo-6,8- diazaspiro[3.4]octan-6-yl]-3- (trifluoromethyl)pyridine-2- carbonitrile::US10981926, Cpd No. 43

SMILES FC(F)(F)c1cc(cnc1C#N)N1C(=S)N(c2ccc(OC3CCNCC3)nc2)C2(CCC2)C1=O

InChI Key InChIKey=OUEHJEYKNYQVRC-UHFFFAOYSA-N

Data  1 KI  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 493530   

TargetAndrogen receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataKi:  3nMAssay Description:ReceptorsGR (human) (agonist radioligand) IM-9 cells (cytosol)[3H]dexamethasone 1.5 nM 1.5 nM triamcinolone (10 μM) 6 h 4° C. Scintillation coun...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetGlucocorticoid receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataIC50: >3.00E+4nMAssay Description:ReceptorsGR (human) (agonist radioligand) IM-9 cells (cytosol)[3H]dexamethasone 1.5 nM 1.5 nM triamcinolone (10 μM) 6 h 4° C. Scintillation coun...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetAndrogen receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataIC50:  37nMAssay Description:Antagonist activity at Androgen receptor F877L mutant in human LNCaP cells measured by transcriptional reporter assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetAndrogen receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataIC50:  54nMAssay Description:Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presen...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataIC50:  54nMAssay Description:Antagonist activity at Androgen receptor in human LNCaP cells measured by transcriptional reporter assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetAndrogen receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataIC50:  6.90nMAssay Description:ReceptorsGR (human) (agonist radioligand) IM-9 cells (cytosol)[3H]dexamethasone 1.5 nM 1.5 nM triamcinolone (10 μM) 6 h 4° C. Scintillation coun...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetAndrogen receptor(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM493530(5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thiox...)
Affinity DataIC50:  37nMAssay Description:Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in pre...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed